Lannett Receives FDA Approval for ANDA Supplement for Phentermine HCL...
PHILADELPHIA — (CRWENEWSWIRE) — Lannett Company, Inc. (NYSE AMEX:LCI) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its supplemental Abbreviated...
View ArticleAthersys Announces Positive Results of MultiStem(R) Clinical Trial for...
Trial Results Could Provide Basis for Accelerating Clinical Development of MultiStem(R) Orphan Drug Candidate CLEVELAND, Feb. 1, 2012 (CRWENEWSWIRE) — Athersys, Inc. (Nasdaq:ATHX) today announced...
View ArticleDiscovery Labs Cleared to Market AFECTAIR in U.S.
New, Proprietary Technology Simplifies Delivery of Aerosolized Medications to Patients Requiring Ventilatory Support WARRINGTON, PA, Feb. 2, 2012 (CRWENEWSWIRE) — Discovery Laboratories, Inc....
View ArticleCatalyst Pharmaceutical Partners Granted Orphan Medicinal Product Designation...
CORAL GABLES, FL, Feb. 13, 2012 (CRWENEWSWIRE) — Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) today announced that the European Commission (EC) has granted orphan medicinal product...
View ArticleTrius Announces Issuance of Tedizolid Patent in China
SAN DIEGO, Feb. 16, 2012 (CRWENEWSWIRE) — Trius Therapeutics, Inc. (Nasdaq:TSRX) announced today the issuance of Patent # 908206 by the State Intellectual Property Office of the People’s Republic of...
View ArticleFDA Advisory Committee Recommends Approval of Qnexa
MOUNTAIN VIEW, Calif., Feb. 22, 2012 (CRWENEWSWIRE) — VIVUS, Inc. (NASDAQ:VVUS) today announced that the U.S. Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee...
View ArticleFDA Advisory Panel Recommends Approval of Chelsea’s NORTHER(TM) (droxidopa)...
CHARLOTTE, NC, Feb. 23, 2012 (CRWENEWSWIRE) — Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today announced that the Food and Drug Administration’s (FDA) Cardiovascular and Renal Drugs...
View ArticleCASMED’s FORE-SIGHT(R) Absolute Tissue Oximeter Gains FDA Clearance for Use...
FORE-SIGHT Oximeter is first tissue oximeter with a specific abdominal claim BRANFORD, Conn., Feb. 27, 2012 (CRWENEWSWIRE) — CAS Medical Systems, Inc. (Nasdaq:CASM), a leader in medical devices for...
View ArticleMeridian Bioscience Receives FDA Clearance for New Legionella Test
CINCINNATI — 02/27/2012 (CRWENEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that it has received FDA clearance from the U.S. Food and Drug Administration (FDA) for TRU...
View ArticleCumberland Pharmaceuticals Signs Exclusive Licensing Agreement for China
Agreement expands international presence of Acetadote(R) and Caldolor(R) NASHVILLE, Tenn., Feb. 28, 2012 (CRWENEWSWIRE) – Cumberland Pharmaceuticals Inc. (Nasdaq:CPIX) today announced it has entered...
View Article
